Applies to zanubrutinib: oral capsules.
Side effects include:
Adverse effects (≥30%): decreased neutrophil count, decreased platelet count, upper respiratory tract infection, hemorrhage, musculoskeletal pain.
For Healthcare Professionals
Applies to zanubrutinib: oral capsule.
Hematologic
Very common (10% or more): All grades neutropenia (up to 56%), all grades thrombocytopenia (up to 45%) , hemorrhage (up to 32%), all grades anemia (up to 28%) , all grades leukopenia (25%)
Common (1% to 10%): Grade 3 or 4 anemia, Grade 3 or 4 leukopenia, Grade 3 or 4 thrombocytopenia[Ref]
Immunologic
Very common (10% or more): Grade 3 or higher infection (23%)[Ref]
Musculoskeletal
Very common (10% or more): Musculoskeletal pain (e.g., musculoskeletal pain, musculoskeletal discomfort, myalgia, back pain, arthralgia, arthritis) (up to 45%), muscle spasms (10%)[Ref]
Metabolic
Very common (10% or more): Glucose increased (45%), blood uric acid increased (up to 29%), hypokalemia (14%), calcium decreased (27%), hyperkalemia (24%), hypophosphatemia (20%)
Genitourinary
Very common (10% or more): Urinary tract infection (up to 15%)[Ref]
Hepatic
Very common (10% or more): ALT increased (28%), bilirubin increased (up to 24%)
Common (1% to 10%): Hepatitis B reactivation[Ref]
Oncologic
Very common (10% or more): Second primary malignancies (13%)[Ref]
Respiratory
Very common (10% or more): Upper respiratory tract infection (up to 44%), pneumonia (up to 22%), cough (up to 21%)[Ref]
Cardiovascular
Very common (10% or more): Hypertension (12%)
Common (1% to 10%): Atrial fibrillation, atrial flutter[Ref]
Dermatologic
Very common (10% or more): Rash (up to 30%), bruising (up to 20%), pruritus (11%)[Ref]
Gastrointestinal
Very common (10% or more): Diarrhea (up to 23%), constipation (up to 16%), nausea (18%)
Uncommon (0.1% to 1%): Gastrointestinal hemorrhage[Ref]
General
The most common adverse events were neutropenia, thrombocytopenia, upper respiratory tract infection, hemorrhage, rash, anemia and musculoskeletal pain.
Renal
Very common (10% or more): Creatinine increased (31%)
Other
Very common (10% or more): Fatigue (up to 15%), peripheral edema (12%), pyrexia (16%)
Common (1% to 10%): Asthenia
Nervous system
Very common (10% or more): Dizziness (11%)